Linperlisib in Combination With CHOP in Previously Untreated Peripheral T-Cell Lymphoma

Summary

This phase Ib/II, single arm, open label, multicenter study is conducted to evaluate the efficacy and safety of linperlisib in combination with CHOP for newly diagnosed PTCL patients, and explore the reasonable dosage of linperlisib when combined with CHOP regimen.

Timeline

Start

2023-08-15

Primary completion

2026-08

Completion

2026-12

Drugs

Indications